Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 13 - Jul 18
For Your Every Summer RSVP, with Code: SUMMER15
Description
Long term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial Nature Medicine STEP HFpEF Trial The Dermatology Digest The US FDA approves the once daily oral form of # semaglutide (Wegovy pill, #NovoNordisk), making it the first oral #GLP1 medicine for Instagram I Cant Believe I Did This My Weight Loss Journey Changed My Life ACG 2024 Annual Meetings Posters
Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
4.5 ★★★★★
Based on 670 reviews
Sort
Product Reviews
★★★★★ 4
SoSo
Color: Black, White, Dark Gray, Size: Small
plain is nice!
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on November 30, 2025
★★★★★ 5
Great shirts
Good quality.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on December 24, 2025
★★★★★ 5
Order a size up
Snug fit. Need a XL
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on July 20, 2025
★★★★★ 1
Dirty and used product stained
Color: Black, White, Dark Gray, Size: Medium
Tshirts were used and dirty
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on March 5, 2026
★★★★★ 3
Good material but runs small.
Runs small, even with a 2x for son who takes a large and wanted extra room.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on July 19, 2025
recommand products
GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art
27.03
Potential Use of GLP-1 and GIP/GLP-1 Receptor Agonists for Respiratory Disorders: Where Are We at?
27.23
GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus
22.91
Evolution of GLP‐1 Receptor Agonists for Diabetes Treatment
24.90
GLP-1 actions in peripheral tissues. The majority of the effects of
24.48